Merck, MABN2313-100UG, Anti-Frataxin Antibody, clone 4F9

General description
Full-length human recombinant Frataxin.
~14 and 18 kDa observed; 23.13 kDa calculated (full length). Uncharacterized bands may be observed in some lysate(s).
Application
Western Blotting Analysis: A representative lot detected Frataxin in Western Blotting applications (Piquet, F., et. al. (2018). Mol Ther. 26(8):1940-1952; Li, L., et. al. (2018). Nucleic Acid Ther. 28(1):23-33).

Biochem/physiol Actions
Clone 4F9 is a mouse monoclonal antibody that specifically detects mature and intermediate forms of human Frataxin.

Physical form
Purified mouse monoclonal antibody IgG2b in buffer containing 0.1M Tris-Glycine, 0.15M NaCl, pH7.4 with 0.05% sodium azide.

Preparation Note
Stable for 1 year at 2-8°C from date of receipt.
Analysis Note
Evaluated by Western Blotting in K562 cell lysate.

Western Blotting Analysis: 1 µg/mL of this antibody detected Frataxin in K562 cell lysate.

Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.